EU Approves Abbott's Humira For Ulcerative Colitis Use
The European Commission has approved Abbott Laboratories' blockbuster anti-inflammatory drug Humira for treatment of adult ulcerative colitis, the company said Wednesday, further expanding the uses of the pharmaceutical giant's top-selling drug....To view the full article, register now.
Already a subscriber? Click here to view full article